Back
NeoGenomics, Inc. Vs. Panbela Therapeutics, Inc. Industry Stock Comparison
Buy
52
NEO
NeoGenomics, Inc.
Last Price:
$11.74
Seasonality Move:
41.42%
Sell
5
PBLA
Panbela Therapeutics, Inc.
Last Price:
$0.0000
Seasonality Move:
-13.55%
Buy
52
NeoGenomics, Inc. (NEO)
is a Buy
Is NeoGenomics, Inc. a Buy, Sell or Hold?
-
The current NeoGenomics, Inc. [NEO] share price is $11.76. The Score for NEO is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
NEO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Panbela Therapeutics, Inc. (PBLA)
is a Sell
Is Panbela Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Panbela Therapeutics, Inc. [PBLA] share price is $0.0002. The Score for PBLA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
-
PBLA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NEO Stock Price Chart
What is NeoGenomics, Inc.'s stock price today?
-
The NeoGenomics, Inc. share price today is $11.76The current trend is moderately bearish and NEO is experiencing selling pressure, which indicates risk of future bearish movement.
PBLA Stock Price Chart
What is Panbela Therapeutics, Inc.'s stock price today?
-
The Panbela Therapeutics, Inc. share price today is $0.0002Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing selling pressure, which indicates risk of future bearish movement.
NEO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 50.17 | Buy |
| Chaikin Money Flow: | -1119133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.78 - 12.26) | Sell |
| Bollinger Bands (100): | (7.66 - 11.5) | Buy |
PBLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 37.43 | Sell |
| Chaikin Money Flow: | -23648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0006 - 0.0206) | Sell |
| Bollinger Bands (100): | (-0.0129 - 0.1071) | Sell |
NEO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.19 | Sell |
| 20-day SMA: | 11.99 | Sell |
| 50-day SMA: | 11.17 | Buy |
| 200-day SMA: | 8.68 | Buy |
| 8-day EMA: | 12.09 | Sell |
| 20-day EMA: | 11.91 | Sell |
| 50-day EMA: | 11.15 | Buy |
| 200-day EMA: | 10.07 | Buy |
PBLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Sell |
| 20-day SMA: | 0.01 | Sell |
| 50-day SMA: | 0.01 | Sell |
| 200-day SMA: | 0.15 | Sell |
| 8-day EMA: | 0 | Sell |
| 20-day EMA: | 0 | Sell |
| 50-day EMA: | 0 | Sell |
| 200-day EMA: | 0 | Buy |
NeoGenomics, Inc. Earnings Growth & NEO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.18 per share.
Panbela Therapeutics, Inc. Earnings Growth & PBLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.00 per share.
NeoGenomics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Panbela Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||